Prevention & lipids

1. JAMA Intern Med8 Sep 2026

   Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms

   Cohort study

2. Eur J Prev Cardiol5 Sep 2026

   Comprehensive risk factor control attenuates excess cardiovascular risk in rheumatoid arthritis: a prospective cohort study

   Cohort study

3. Eur J Prev Cardiol4 Sep 2026

   Use of Mediterranean diet adherence and physical activity for refining cardiovascular risk prediction in the general population - insights from the CoLaus/PsyCoLaus study

   Cohort study

4. Eur J Prev Cardiol4 Sep 2026

   SCORE2-OP-guided statin initiation for primary prevention in adults aged 70–89 years without diabetes: evidence for age-specific risk thresholds

   Cohort study

5. Eur J Prev Cardiol4 Sep 2026

   Cardiorespiratory fitness and population attributable risk: the ETHOS study

   Cohort study

6. Eur J Prev Cardiol4 Sep 2026

   Depressive symptom trajectories across the transition to cardiovascular disease in middle-aged and older adults: a multicohort study

   Cohort study

7. Eur J Prev Cardiol1 Sep 2026

   Cigarette smoking, coronary plaque burden and phenotype: a multimodality meta-analysis and implications for coronary artery calcium scoring in prevention

   Meta-analysis

8. Eur Heart J1 Sep 2026

   Adverse pregnancy outcomes and long-term cardiovascular risk: lifelong connections

   Research article

9. JAMA Cardiol1 Sep 2026

   Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning

   Diagnostic or prognostic study

10. JAMA Cardiol1 Sep 2026

    Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease: The SAPPHIRE-LDL Cluster Randomized Clinical Trial

    Randomised controlled trial

11. JACC Adv31 Aug 2026

    Association Between Hypertensive Disorders of Pregnancy, Lifestyle Factors, and Premature Cardiovascular Events

    Cohort study

12. Circ Popul Health Outcomes31 Aug 2026

    Assessing Differences Between Epigenetic versus Chronologic Age for Cardiovascular Risk Assessments in the United States

    Cross-sectional study

13. J Am Coll Cardiol31 Aug 2026

    Effect on Lipoprotein(a) Oxidized Phospholipids of Lepodisiran, an Extended-Duration siRNA Targeting Lipoprotein(a)

    Secondary analysis

14. Circulation31 Aug 2026

    Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial

    Secondary analysis

15. Eur Heart J31 Aug 2026

    Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-challenge trial

    Randomised controlled trial

16. Eur Heart J31 Aug 2026

    Apolipoprotein B-containing lipoproteins: distinct roles in atherosclerosis revealed by plasma proteomic profiling

    Cohort study

17. Eur J Prev Cardiol31 Aug 2026

    Lipoprotein(a) distributions and trial eligibility thresholds for Lp(a)-lowering therapies in the general population: the Rotterdam study

    Cross-sectional study

18. Circulation30 Aug 2026

    Lipoprotein(a) and Atherosclerotic Cardiovascular Disease Among Adults Aged 20 to 100 Years

    Cohort study

19. Eur Heart J30 Aug 2026

    Cardiovascular Prevention among Healthcare Professionals: the ESC Congress Cardiovascular Health Check 2025

    Cross-sectional study

20. Circ Popul Health Outcomes30 Aug 2026

    Lipoprotein (a) Testing and Changes in Lipid-Lowering Therapy in Patients With ASCVD: Findings From the cvMOBIUS-2 Registry

    Cohort study

21. Eur J Prev Cardiol30 Aug 2026

    Fitness does not retire: cardiorespiratory fitness and risk of major adverse cardiovascular events in older adults

    Cohort study

22. JAMA29 Aug 2026

    Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical Trial

    Randomised controlled trial

23. N Engl J Med29 Aug 2026

    Prevalence of Silent Atherosclerosis across Adult Life

    Cohort study

24. Lancet28 Aug 2026

    Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

    Randomised controlled trial

25. J Am Coll Cardiol28 Aug 2026

    Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study

    Secondary analysis

26. Eur J Prev Cardiol28 Aug 2026

    Coronary computed tomography angiography to guide lipid management in an asymptomatic community-based population: RESPECT2 randomized controlled trial

    Randomised controlled trial

27. Eur J Prev Cardiol27 Aug 2026

    Cardiovascular risk management in the elderly: a dilemma in daily clinical practice

    Research article

28. Eur J Prev Cardiol27 Aug 2026

    Low cardiovascular risk in early midlife and quality of life in old age: a life-long follow-up study in men

    Cohort study

29. JACC Adv26 Aug 2026

    Multichamber Myocardial Strain for Cardiovascular Risk Stratification in Liver Transplant Recipients Using Interpretable Machine Learning

    Research article

30. Eur Heart J Qual Care Clin Outcomes26 Aug 2026

    Recording of hypertensive disorders of pregnancy and subsequent cardiovascular risk among New Zealand women

    Cohort study

31. Eur J Prev Cardiol25 Aug 2026

    Worsening trends in modifiable cardiovascular risk factors among patients hospitalized for cardiovascular disease in Spain (2007–22): a nationwide sex-specific analysis

    Cohort study

32. JACC Adv22 Aug 2026

    Event-Driven Intensification and Persistent Therapeutic Inertia in LDL-C Management Among 1,033,703 Patients With ASCVD

    Cohort study

33. JACC Adv19 Aug 2026

    Patterns in Cardiovascular Risk Factors Stratified by Age and Sex in a Large German Population

    Cross-sectional study

34. JACC Adv19 Aug 2026

    Lipid-Lowering Therapy Preferences in the LISTEN-LDL-US Study: A Survey of U.S. Patient Treatment Experiences and Needs

    Cross-sectional study

35. JACC Adv19 Aug 2026

    E-Cigarette Use and Early Cardiovascular Risk in Young Adults: The VapeScan Study

    Cross-sectional study

36. Eur Heart J Acute Cardiovasc Care19 Aug 2026

    Frailty assessment and the risk of major adverse cardiovascular events after elective surgery

    Cohort study

37. JAMA18 Aug 2026

    Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy

    Cross-sectional study

38. Eur J Prev Cardiol18 Aug 2026

    New insights into statin-intolerance: biopsychosocial differences, medication beliefs, trust in healthcare, and treatment decisions in statin-intolerant vs. statin-tolerant patients

    Cross-sectional study

39. JAMA18 Aug 2026

    Prevalence of LDL-C Above 2026 Dyslipidemia Guideline Goals Among US Adults

    Cross-sectional study

40. Eur J Prev Cardiol17 Aug 2026

    Longitudinal changes of cardiorespiratory fitness are associated with cardiovascular disease and mortality: evidence from the UK Biobank

    Cohort study

All 838 Briefs in ExploreShowing Briefs 41–80 of 838, newest first